Monoclonal antibodies are antibodies that are produced by a single (mono) set of genetically identical plasma cells (a clone).
Mabs are produced when a particular B-cell divides by mitosis to form a clone of itself, including plasma cells, which secrete many specific antibodies.
Since the clone is produced from a single plasma cell, all of the cells secrete the same, specific antibody (the Mabs).
It is now possible to produce a large clone of plasma cells in the laboratory.
Mabs can be produced that have complementary shapes to abnormal proteins (antigens) on a particular type of cancer cell. This avoids potential harm to body cells as the receptors are different and so the antibodies cannot bind.
The production of Mabs in a laboratory opens up many new techniques for the research, diagnosis, and treatment of medical disorders.
To fight autoimmune diseases (e.g. Rheumatoid arthritis or Crohn's disease), Mabs have been created to disable the substance TNF-alpha (which is involved in the response). The disabling of TNF-alpha calms down the immune system's attack and reduces the symptoms of this disease.